362 related articles for article (PubMed ID: 27459275)
21. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
22. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.
Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG
Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672
[TBL] [Abstract][Full Text] [Related]
23. Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.
Annereau JP; Szakács G; Tucker CJ; Arciello A; Cardarelli C; Collins J; Grissom S; Zeeberg BR; Reinhold W; Weinstein JN; Pommier Y; Paules RS; Gottesman MM
Mol Pharmacol; 2004 Dec; 66(6):1397-405. PubMed ID: 15342794
[TBL] [Abstract][Full Text] [Related]
24. ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H; Cascorbi I
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):369-396. PubMed ID: 33459081
[TBL] [Abstract][Full Text] [Related]
25. Curcumin as chemosensitizer.
Limtrakul P
Adv Exp Med Biol; 2007; 595():269-300. PubMed ID: 17569216
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
[TBL] [Abstract][Full Text] [Related]
27. [Up-to-date approaches to clinical estimate of phenotype of multiple drug resistance associated with function of ABC-transporters in human solid tumors].
Bogush EA; Kirsanov VIu
Antibiot Khimioter; 2006; 51(9-10):50-5. PubMed ID: 18030792
[TBL] [Abstract][Full Text] [Related]
28. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS
Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094
[TBL] [Abstract][Full Text] [Related]
29. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
[TBL] [Abstract][Full Text] [Related]
30. ABC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():13-100. PubMed ID: 31571164
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
Lockhart AC; Tirona RG; Kim RB
Mol Cancer Ther; 2003 Jul; 2(7):685-98. PubMed ID: 12883042
[TBL] [Abstract][Full Text] [Related]
32. What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.
Briz O; Perez-Silva L; Al-Abdulla R; Abete L; Reviejo M; Romero MR; Marin JJG
Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):577-593. PubMed ID: 31185182
[No Abstract] [Full Text] [Related]
33. Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray.
Liu Y; Peng H; Zhang JT
Mol Pharmacol; 2005 Aug; 68(2):430-8. PubMed ID: 15901850
[TBL] [Abstract][Full Text] [Related]
34. Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents.
Beretta GL; Cassinelli G; Pennati M; Zuco V; Gatti L
Eur J Med Chem; 2017 Dec; 142():271-289. PubMed ID: 28851502
[TBL] [Abstract][Full Text] [Related]
35. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
[TBL] [Abstract][Full Text] [Related]
36. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.
Shukla S; Wu CP; Ambudkar SV
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):205-23. PubMed ID: 18248313
[TBL] [Abstract][Full Text] [Related]
37. Progress in characterizing ABC multidrug transporters in zebrafish.
Thomas JR; Frye WJE; Robey RW; Gottesman MM
Drug Resist Updat; 2024 Jan; 72():101035. PubMed ID: 38141369
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of ABC drug transporters.
Scotto KW
Oncogene; 2003 Oct; 22(47):7496-511. PubMed ID: 14576854
[TBL] [Abstract][Full Text] [Related]
39. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
[TBL] [Abstract][Full Text] [Related]
40. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
